Two-Stage Deep-Learning Classifier for Diagnostics of Lung Cancer Using Metabolites

Author:

Choudhary Ashvin1ORCID,Yu Jianpeng2,Kouznetsova Valentina L.345,Kesari Santosh6,Tsigelny Igor F.3457

Affiliation:

1. School of Life Science, University of California, Los Angeles, CA 90095, USA

2. School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA

3. San Diego Supercomputer Center, University of California, San Diego, CA 92093, USA

4. IUL, La Jolla, CA 92038, USA

5. CureScience Institute, San Diego, CA 92121, USA

6. Pacific Neuroscience Institute, Santa Monica, CA 90404, USA

7. Department of Neurosciences, University of California, San Diego, CA 92093, USA

Abstract

We developed a machine-learning system for the selective diagnostics of adenocarcinoma (AD), squamous cell carcinoma (SQ), and small-cell carcinoma lung (SC) cancers based on their metabolomic profiles. The system is organized as two-stage binary classifiers. The best accuracy for classification is 92%. We used the biomarkers sets that contain mostly metabolites related to cancer development. Compared to traditional methods, which exclude hierarchical classification, our method splits a challenging multiclass task into smaller tasks. This allows a two-stage classifier, which is more accurate in the scenario of lung cancer classification. Compared to traditional methods, such a “divide and conquer strategy” gives much more accurate and explainable results. Such methods, including our algorithm, allow for the systematic tracking of each computational step.

Publisher

MDPI AG

Subject

Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference37 articles.

1. SEER (2023, May 14). Cancer of the Lung and Bronchus—Cancer Stat Facts, Available online: https://seer.cancer.gov/statfacts/html/lungb.html.

2. Petkevicius, J., Simeliunaite, I., and Zaveckiene, J. (2018, January 24–26). Multivariable appearance of LAC and its subtypes on CT images. Proceedings of the ESTI ESCR 2018 Congress, Geneva, Switzerland. Available online: https://epos.myesr.org/poster/esr/esti-escr2018/P-0086.

3. Cell death-based treatment of lung adenocarcinoma;Denisenko;Cell Death Dis.,2018

4. Small Cell Lung Cancer;Reckamp;Lung Cancer: Treatment and Research,2016

5. Huang, T., Li, J., Zhang, C., Hong, Q., Jiang, D., Ye, M., and Duan, S. (2016). Distinguishing lung adenocarcinoma from lung squamous cell carcinoma by two hypomethylated and three hypermethylated genes: A meta-analysis. PLoS ONE, 11.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3